Barrett’s Oesophagus and Bariatric/Metabolic Surgery—IFSO 2020 Position Statement

Oliver M. Fisher, Daniel L. Chan, Michael L. Talbot, Almino Ramos, Ahmad Bashir, Miguel F. Herrera, Jacques Himpens, Scott Shikora, Kelvin D. Higa, Lilian Kow, Wendy A. Brown

Research output: Contribution to journalArticleResearchpeer-review

1 Citation (Scopus)


The International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) has been playing an integral role in educating both the metabolic surgical and the medical community at large about the importance of surgical and/or endoscopic interventions in treating adiposity-based chronic diseases. The occurrence of chronic conditions following bariatric/metabolic surgery (BMS), such as gastro-oesophageal reflux disease (GERD) and columnar (intestinal) epithelial metaplasia of the distal oesophagus (also known as Barrett’s oesophagus (BE)), has long been discussed in the metabolic surgical and medical community. Equally, the risk of neoplastic progression of Barrett’s oesophagus to oesophageal adenocarcinoma (EAC) and the resulting requirement for surgery are the source of some concern for many involved in the care of these patients, as the surgical alteration of the gastrointestinal tract may lead to impaired reconstructive options. As such, there is a requirement for guidance of the community.The IFSO commissioned a task force to elucidate three aspects of the presenting problem: First, to determine what the estimated incidence of Barrett’s oesophagus is in patients presenting for BMS; second, to determine the frequency at which Barrett’s oesophagus may develop following BMS (with a particular focus on the laparoscopic sleeve gastrectomy (LSG)); and third, to determine if regression of Barrett’s oesophagus may occur following BMS given the close relationship of obesity and the development of BE/EAC. Based on these findings, a position statement regarding the management of this pathology in the context of BMS was developed. The following position statement is issued by the IFSO Barrett’s Oesophagus task force andapproved by the IFSO Scientific Committee and Executive Board. This statement is based on current clinical knowledge, expert opinion and published peer-reviewed scientific evidence. It will be reviewed regularly.

Original languageEnglish
Pages (from-to)915-934
Number of pages20
JournalObesity Surgery
Issue number3
Publication statusPublished - Mar 2021


  • Bariatric/metabolic surgery
  • Barrett’s oesophagus
  • Gastric bypass
  • Obesity
  • Sleeve gastrectomy
  • Weight loss surgery

Cite this